Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201401025 Principal Investigator: Wang-Gillam, Andrea
Title: A Phase 2B, Randomized, Controlled, Multicenter, Open-Label Study of the Efficacy and Immune Response of GVAX Pancreas Vaccine (with Cyclophosphamide) and CRS-207 Compared to Chemotherapy or to CRS-207 Alone in Adults with Previously-Treated Metastatic Pancreatic Adenocarcinoma
Phase: II Disease Site: Pancreas
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to test whether GVAX pancreas vaccine and CRS-207 together are safe and work better than chemotherapy to treat patients with advanced pancreatic cancer who have received at least one prior chemotherapy treatment for cancer that has spread beyond the pancreas.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)